Summary by Moomoo AI
Four Circle Pharmaceutical Holdings Group Limited will hold its Annual General Meeting in Shenzhen on 7 June 2024. The proceedings will include the approval of the 2023 financial statements and reports, the election and remuneration of directors and auditors, and the granting of the Board of Directors powers to distribute and repurchase shares. THE MEETING WILL RE-ELECT DR. CHE FENG SHENG AS EXECUTIVE DIRECTOR, MR. TSANG HUA KWONG AND DR. CHU XUN AS INDEPENDENT NON-EXECUTIVE DIRECTORS, AND RESUME THE APPOINTMENT OF EY ACCOUNTING FIRM AS AUDITORS. In addition, the Board of Directors will seek general authorization to issue new shares not exceeding 20% of the total issued shares and to repurchase no more than 10% in the coming year. The registration of shares will be suspended from 3 to 7 June to determine the right of shareholders to attend the general meeting and vote.